Prolonged Suppression of Corticosteroid-Binding Globulin by Recombinant Human Interleukin-6 in Man
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Corticosteroid-binding globulin (CBG), a glucoprotein of hepatic origin, binds cortisol and modifies its bioavailability (1). Interleukin-6 (IL-6) dose-dependently inhibits CBG messenger RNA expression and protein secretion by hepatoblastoma-derived (HepG2) cells (2). This is consistent with the presence of a nuclear factor-IL-6-binding site in the rat CBG gene promoter, also conserved in the promoter of the human CBG gene (3). These findings suggest that CBG is a negative acute phase reactant protein. We recently reported the results of a dose-response study of single subcutaneous injections of recombinant human IL-6 on pituitary hormone production and glucose metabolism in healthy male volunteers (4, 5). We hereby provide evidence from these volunteers that supports the inhibitory effect of IL-6 on CBG production. We measured CBG (6), cortisol, and the positive acute phase reactant C-reactive protein (CRP) at baseline, then at 24 h, 48 h, and 7 days after the IL-6 injection in three volunteers who received 0.3 μg/kg of IL-6, a dose that did not activate the hypothalamic-pituitary-adrenal (HPA) axis and in three volunteers who received 3.0 μg/kg of IL-6, a dose that strongly stimulated the HPA axis (4). Plasma IL-6 levels reached a peak of 22 ± 5 pg/mL and 290 ± 38 pg/mL for the two doses respectively, between 2 and 4 h after the injection, and returned to baseline by 24 h in both groups. While the 0.3 μg/kg dose did not appreciably influence plasma CBC levels, the 3.0 μg/kg dose caused a significant and persistent decrease in CBC levels that lasted at least 48 h, but returned to baseline by 7 days (Fig. 1).The corresponding CRP levels showed a mirror image response, increasing significantly by 24 h (from 0.77 ± 0.06 mg/dL to 9.8 ± 1.01 mg/dL, P < 0.01), remaining elevated at 48 h (6.0 ± 1.24, P < 0.05 vs. baseline) and returning to normal by 7 days (0.75 ± 0.05 mg/dL). Cortisol levels, despite the dramatic response observed during the first 4 h after the IL-6 injection (4), were at baseline by 24 h and remained so thereafter. It is of note that the plasma IL-6 concentrations reached after the 3.0μ g/kg dose are within the range of plasma IL-6 concentrations previously reported in septic patients or during acute trauma and surgery (7, 8) and that CBG levels are dramatically decreased in such patients, suggesting that hepatic production of CBG is inhibited. The in vitro data of Emptoz-Bonneron et al. (2) and our findings in healthy humans suggest that IL-6 is a regulator of CBG production and, hence, a determinant of cortisol bioavailability. Mean ± se plasma CBG responses to the two doses (0.3 and 3.0 μg/kg) of recombinant human IL-6 administration. * P < 0.02 by paired t-test. Mean ± se plasma CBG responses to the two doses (0.3 and 3.0 μg/kg) of recombinant human IL-6 administration. * P < 0.02 by paired t-test.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Defensor, R., Mitsiadis, C. S., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4422 · Cited by 324
Self-citationTsigos, C., Papanicolaou, D. A., Defensor, R., Mitsiadis, C. S., Kyrou, I., & Chrousos, G. P. (2008) · Neuroendocrinology · doi:10.1159/000127219 · Cited by 223
Self-citationHigh fluid intake increases urine free cortisol excretion in normal subjects.
Mericq, M. V., & Cutler, G. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4555 · Cited by 111
Emptoz-Bonneton, A., Crave, J. C., Lejeune, H., Brébant, C., & Pugeat, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4362 · Cited by 68
Cited by
Plasma binding proteins as mediators of corticosteroid action in vertebrates
Breuner, C., & Orchinik, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750099 · Cited by 457
“1989); interleukin-6 decreases CBG capacity (Tsigos et al. 1998); and altering CORT levels (through implant, injection or adrenalectomy) can increase or decrease CBG capacity, depending on the species or developmental stage (Feldman et al.”
BackgroundGranger, D. A., Hibel, L. C., Fortunato, C. K., & Kapelewski, C. H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.017 · Cited by 295
Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control
Lang Lehrskov, L., Lyngbaek, M. P., Soederlund, L., Legaard, G. E., Ehses, J. A., Heywood, S. E., Wewer Albrechtsen, N. J., Holst, J. J., Karstoft, K., Pedersen, B. K., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.008 · Cited by 135
Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects
Rohleder, N., Wolf, J. M., & Kirschbaum, C. (2003) · Stress · doi:10.1080/1025389031000153658 · Cited by 118
“Furthermore, short-term treatment with the cytokine IL-6 was shown to induce a rapid decrease of CBG levels in healthy volunteers (Tsigos et al., 1998).”
BackgroundDose-Dependent Effects of Recombinant Human Interleukin-6 on the Pituitary-Testicular Axis
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Raptis, S. A., & Chrousos, G. P. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099312948 · Cited by 111
Self-citation
Metadata
- Authors
- Tsigos, C.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-09-01
- Volume
- 83
- Issue
- 9
- Pages
- 3379-3379
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W1984660882
- Cited by
- 50
- References
- 5
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prolonged Suppression of Corticosteroid-Binding Globulin by Recombinant Human Interleukin-6 in Man. https://app.cochat.ai/papers/10.1210/jc.83.9.3379
- The paper
- Tsigos, C. (1998). Prolonged Suppression of Corticosteroid-Binding Globulin by Recombinant Human Interleukin-6 in Man. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.83.9.3379
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.